RA Capital Management, L.P. 13D/13G Filings for Milestone Pharmaceuticals Inc. (MIST)

RA Capital Management, L.P. 13D and 13G filings for Milestone Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-14
4:45 pm
Sale
2022-12-3113GMilestone Pharmaceuticals Inc.
MIST
RA Capital Management, L.P.0
0.000%
-2,246,503decrease
(Position Closed)
Filing
2022-02-14
4:11 pm
Sale
2021-12-3113GMilestone Pharmaceuticals Inc.
MIST
RA Capital Management, L.P.2,246,503
7.500%
-81,211decrease
(-3.49%)
Filing
2021-02-16
4:39 pm
Purchase
2020-12-3113GMilestone Pharmaceuticals Inc.
MIST
RA Capital Management, L.P.2,327,714
7.800%
2,327,714increase
(New Position)
Filing